MediPharm Labs and Argentia Gold To Supply Cannabis Products To Canada

Supply arrangement to bring premium cannabis-infused products to Atlantic Canada.

MediPharm Labs Corp. (TSX: LABS) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products and Argentia Gold Corporation, a Canadian vertically integrated licensed producer, today announced the formation of a supply arrangement to bring premium cannabis-infused products to Atlantic Canada.

We are committed to delivering the highest quality products to our customers throughout Atlantic Canada and doing so in partnership with MediPharm Labs is a virtual guarantee of success.Dave Thomson, President of Argentia Gold

Under the agreement, which has an initial 2-year term, MediPharm Labs will provide Argentia Gold-branded formulated tincture bottles of CBD cannabis resin and Argentia Gold will provide distribution, sales, and service to leading retailers in Newfoundland and Labrador, Prince Edward Island, Nova Scotia and New Brunswick.

"As our white-label supply partner, MediPharm Labs is able to address exactly what we need: reliable, responsive production that meets Good Manufacturing Practice standards backed by some of the cannabis industry's most knowledgeable scientists, pharmaceutical professionals and extraction specialists. Argentia Gold's destination is market leadership and this agreement is an important milestone in our journey," said Dave Thomson, President of Argentia Gold.

Canadian consumption rates for cannabis are the highest per capita in Atlantic Canada (up to 26.8 percent in Nova Scotia, 25.2 per cent for Newfoundland, 23.2 per cent for Prince Edward Islandi). In comparison, the cannabis consumption rate for Ontario is up to 18.1 per centii.

"Consumers in Atlantic Canada deserve only the very best quality cannabis-infused products and that's exactly what they will receive as a result of this exciting partnership," said Pat McCutcheon, CEO of MediPharm Labs. "Argentia Gold is deeply invested in their community, understands the market, knows local preferences and with a trusted portfolio of premium products will no doubt grow into one of Canada's foremost licensed producers. We are very proud to play a formative role in the next stage of their development."

To learn more about MediPharm Labs, visit the company HQ here.

Disclaimer: Past performance is not an indicator of future performance.

Get the Latest Marijuana News &
Content in your Inbox!

All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors

Casey Peternell
Casey Peternell

Casey is a media and content creator with a keen eye for creativity. Casey is currently in the process of obtaining a double bachelors degree in Media & Communications and Business from Swinburne University in Melbourne.

Leave a Reply

Your email address will not be published. Required fields are marked *